CompuGroup Medical Promotion: Führungswechsel brings fresh wind – tecdax – Börsennachrichten

The CompuGroup Medical SE & Co. KGaA has used part of the Umbruch in the Unternehmensführung. At the end of July, Prof. Dr. Daniel Gotthardt, chairman of the Unternehmensgründers, the new CEO of the Spitze of the Koblenzer Gesundheits-IT-Spezialisten. Dieser Schritt is committed to strengthening the family tradition with the modernization of the internal structure. The active response will take place on the flight current, but the day may be less concave.

Herausforderungen in the dynamic Marktumfeld

Trotz der positiven Signale duch de Führungswechsel steht CompuGroup Medical voor erheblichen Herausforderungen. There is a legislative effort in the management of general IT and the increasing Anforderungen and Datensicherheit and Digitalization in Gesundheitswesen ensure continuous innovation. Analysts see the short-term strategy for the action that is likely to be implemented, while Gotthardt junior’s new strategy will continue for a longer period.

Anzeige

CompuGroup Medical Action: Buy or sell?! Neue CompuGroup MedicalAnalyzefrom 27. September loves Antwort:

The noses of CompuGroup Medical-Zahlen speak clearly: Urgent Handlongsbedarf for CompuGroup Medical-Aktionäre. Do you want to make a purchase or another purchase? The time had come in the free analysis of September 27.

CompuGroup Medical: buy or sell? Read more here…